Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinoma

Forrest, M. Laird

dc.contributor.author	Forrest, M. Laird
dc.date.accessioned	2013-04-23T00:02:05Z
dc.date.available	2013-04-23T00:02:05Z
dc.date.issued	2013-04-01
dc.identifier.citation	JAMA Otolaryngol Head Neck Surg. 2013 Apr 1;139(4):382-387. http://www.dx.doi.org/10.1001/jamaoto.2013.214
dc.identifier.other	PMID: 23599074
dc.identifier.uri	http://hdl.handle.net/1808/11062
dc.publisher	JAMA otolaryngology-- head & neck surgery
dc.title	Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinoma
dc.type	Article
kusw.kuauthor	Forrest, M. Laird
dc.identifier.doi	10.1001/jamaoto.2013.214
kusw.oaversion	Scholarly/refereed, author accepted manuscript
kusw.oapolicy	This item does not meet KU Open Access policy criteria.
dc.rights.accessrights	openAccess

Files in this item

Name:: ooa130011_382_387 (1).pdf
Size:: 252.7Kb
Format:: PDF

View/Open

This item appears in the following Collection(s)

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.